|
|
|
|
|
|
by psychphysic
1218 days ago
|
|
|
If it's cost effective probably <5 years, somewhere it'll see screening usage. Wide spread rollout who knows. But FebriDX was relatively new when it was rolled out in parts of the UK. And with the "COVID backlog" if this is cost effective (which includes if it even works), it'll see usage somewhere like substance misuse clinics. |
|
|